Table 6: Tourniquet versus no tourniquet: study details and qualitative outcomes
Study | n treatment/ control | Comparison | Supplemental analgesic | VAS scores and type of pain, where specified | Time to first analgesic request | Use of supplemental analgesic | Other important outcomes |
(LoE 1) | 40/40 | Surgery with tourniquet inflated (exsanguinated limb) (T) vs. surgery without tourniquet inflated (Cont) | Postop: IM papaveretum (10–20 mg) | Cont superior (p<0.05) at the only time recorded (i.e. 4 h) | __ | IM analgesia: Cont superior (T every 4 h, Cont about every 6 h; p<0.05); oral analgesia: NS by day 3 | Functional outcomes Time to straight-leg raising: Cont superior (p<0.05); range of active knee flexion: Cont superior at days 5 and 10 and at 6 weeks (note that text states significant differences, but p values are not given, and the table does not indicate significant differences); NS at 1 year postop; HSS score (function, pain): NS at 1 year and 2 years postop Hospital stay Length of hospital stay: NS |
(LoE 1) | 40/40 | Surgery with tourniquet inflated (exsanguinated limb) (T) vs. surgery without tourniquet (Cont) | Postop: PCA-morphine sulphate, IV | T superior at 6 h (p=0.0458), but NS at 24 or 48 h | __ | Mean morphine requirement: NS over 1st 2 days | Functional outcomes Range of motion: T superior at day 5 (p<0.001), but NS on day 10 or at 3 months Complications Suction drainage blood loss and total number of blood units transfused: NS; overall blood loss: T superior (p=0.0165) Hospital stay Length of hospital stay: NS |
(LoE 1) | 37/40 | Surgery with tourniquet inflated (exsanguinated limb) (T) vs. surgery without tourniquet (Cont) | Postop: PCA-morphine, IV | NS at 1 week, 6 weeks or 4 months (i.e. at all time points recorded) | __ | Mean morphine requirement: NS at the time points recorded (i.e. 12 and 24 h) | Functional outcomes Knee flexion and mean change in knee flexion: Cont superior at 1 week (p=0.03, in both cases), but NS at 6 weeks and 4 months Complications Blood loss, swelling, wound complications: NS |